These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24778352)

  • 21. Deformable registration of trans-rectal ultrasound (TRUS) and magnetic resonance imaging (MRI) for focal prostate brachytherapy.
    Mayer A; Zholkover A; Portnoy O; Raviv G; Konen E; Symon Z
    Int J Comput Assist Radiol Surg; 2016 Jun; 11(6):1015-23. PubMed ID: 27017500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
    Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-echo gradient recalled echo imaging of the pelvis for improved depiction of brachytherapy seeds and fiducial markers facilitating radiotherapy planning and treatment of prostatic carcinoma.
    Schieda N; Avruch L; Shabana WM; Malone SC
    J Magn Reson Imaging; 2015 Mar; 41(3):715-20. PubMed ID: 24510444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
    Roberson PL; McLaughlin PW; Narayana V; Troyer S; Hixson GV; Kessler ML
    Med Phys; 2005 Feb; 32(2):473-82. PubMed ID: 15789594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.
    Vicini FA; Kini VR; Edmundson G; Gustafson GS; Stromberg J; Martinez A
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):483-91. PubMed ID: 10348275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation.
    McLaughlin PW; Narayana V; Drake DG; Miller BM; Marsh L; Chan J; Gonda R; Winfield RJ; Roberson PL
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):703-11. PubMed ID: 12377321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images.
    Singhrao K; Fu J; Parikh NR; Mikaeilian AG; Ruan D; Kishan AU; Lewis JH
    Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy.
    Sanders JW; Lewis GD; Thames HD; Kudchadker RJ; Venkatesan AM; Bruno TL; Ma J; Pagel MD; Frank SJ
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1292-1303. PubMed ID: 32634543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
    Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
    J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience.
    Bloch BN; Lenkinski RE; Helbich TH; Ngo L; Oismueller R; Jaromi S; Kubin K; Hawliczek R; Kaplan ID; Rofsky NM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):70-8. PubMed ID: 17513062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
    Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
    J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automatic segmentation of radiographic fiducial and seeds from X-ray images in prostate brachytherapy.
    Kuo N; Deguet A; Song DY; Burdette EC; Prince JL; Lee J
    Med Eng Phys; 2012 Jan; 34(1):64-77. PubMed ID: 21802975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients.
    Nosrati R; Song WY; Wronski M; Pejović-Milić A; Morton G; Stanisz GJ
    Brachytherapy; 2019; 18(6):863-874. PubMed ID: 31337542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
    Tanaka O; Komeda H; Hirose S; Taniguchi T; Ono K; Matsuo M
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e405-e411. PubMed ID: 29193796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.